Hasil Pencarian  ::  Simpan CSV :: Kembali

"Pemantauan Terapi Obat (PTO) adalah kegiatan yang memastikan pengobatan yang diberikan kepada pasien efektif, aman, dan rasional. Pemantauan terapi obat mencakup pemantauan efikasi dan interaksi obat, efek toksik, serta kepatuhan pasien. Penelitian ini bertujuan untuk menganalisis Masalah Terkait Obat (MTO) yang terjadi pada pengobatan pasien dan memberikan rekomendasi tindak lanjut menggunakan metode SOAP. Pengumpulan data pasien dilakukan dengan melihat data pasien pada rekam medis dan status pasien yang terdapat pada AVICENNA. Jenis data yang digunakan bersifat narasi, uraian serta penjelasan data dari informan baik lisan maupun perilaku subjek yang diamati di lapangan. Hasil penelitian menunjukkan adanya pemberian terapi obat ISDN tanpa indikasi, ketidaksesuaian dosis penggunaan omeprazole apabila dibandingkan berdasarkan dosis harian renal drug handbook. Kemudian terdapat pemilihan terapi yang kurang tepat dikarenakan adanya duplikasi terapi antihipertensi CCB dan kurang tepatnya pemilihan terapi antihipertensi yang digunakan pada pasien. Adanya potensi interaksi obat pada CaCO3 dengan nifedipie (adalat oros), amlodipine dan bisoprolol sehingga perlu dijeda dalam pemberian obat dan pemantauan tekanan darah pasien. Hasil analisis MTO diinterpretasikan dalam bentuk SOAP sebagai komunikasi tertulis untuk menyampaikan rekomendasi kepada dokter penanggung jawab pelayanan (DPJP).

---

Drug Therapy Monitoring is an activity that ensures that the treatment given to patients is effective, safe and rational. Monitoring drug therapy includes monitoring drug efficacy and interactions, toxic effects, and patient compliance. This study aims to analyze Medication Related Problems that occur during patient treatment and provide follow-up recommendations using the SOAP method. Patient data is collected by looking at patient data in medical records and patient status in AVICENNA. The type of data used is narrative, description and explanation of data from informants both verbally and subject behavior observed in the field. The results of the study showed that ISDN drug therapy was given without indication, and there was a discrepancy in the dose of omeprazole when compared based on the daily dose of the renal drug handbook. Then there is inappropriate selection of therapy due to duplication of CCB antihypertensive therapy and inaccurate selection of antihypertensive therapy used in patients. There is a potential for drug interactions in CaCO3 with nifedipine (adalat oros), amlodipine and bisoprolol so it is necessary to pause in administering the drug and monitoring the patient's blood pressure. The results of the Medication Related Problems analysis are interpreted in SOAP form as written communication to convey recommendations to the doctor in charge of services (DPJP)"

"Hypertensive Heart Disease (HHD) merupakan penyebab utama penyakit dan kematian akibat hipertensi. Gagal ginjal kronis atau Chronic Kidney Disease (CKD) adalah kondisi penurunan fungsi ginjal. CKD dapat terjadi karerna kerusakan progresif akibat tekanan darah tinggi pada kapiler-kapiler ginjal. CKD dan penyakit kardiovaskular saling terkait. Dilakukan pengambilan data pada pasien dengan cara observasi dengan melakukan visite. Selanjutnya dilakukan studi literatur melalui data rekam medis pasien, e-book, peraturan pemerintah, maupun sumber lain. Diperoleh hasil bahwa pasien memiliki diagnosis Hypertensive Heart Disease (HHD), Chronic Kidney Disease (CKD) stage V, Diabetes Melitus (DM), anemia, efusi pleura, pneumonia dan terdapat interaksi obat kategori major antara clonidine dan bisoprolol yang menyebabkan bradikardia dan hipotensi sehingga perlu dilakukan pemantauan tekanan darah serta terdapat potensi interaksi obat kategori major antara candesartan dan spironolactone yang menyebabkan hiperkalemia sehingga perlu dilakukan pemantauan nilai kalium. Hasil analisis DRP disajikan dalam SOAP sebagai komunikasi tertulis untuk menyampaikan rekomendasi kepada dokter penanggung jawab (DPJP).

---

Hypertensive heart disease (HHD) is the leading cause of illness and death from hypertension. Chronic Kidney Disease (CKD) is a condition of decreased kidney function. CKD can occur due to progressive damage caused by high blood pressure to the renal capillaries. CKD and cardiovascular disease are interrelated. Data was collected from the patient by observation by conducting a visit. Furthermore, a literature study was conducted through patient medical record data, e-books, government regulations, and other sources. The results showed that the patient had a diagnosis of Hypertensive Heart Disease (HHD), Chronic Kidney Disease (CKD) stage V, Diabetes Mellitus (DM), anemia, pleural effusion, pneumonia and there was a major category drug interaction between clonidine and bisoprolol which caused bradycardia and hypotension so it was necessary to monitor blood pressure and there was a potential major category drug interaction between candesartan and spironolactone which caused hyperkalemia so it was necessary to monitor potassium values. The results of the DRP analysis are presented in SOAP as written communication to convey recommendations to the doctor in charge (DPJP)."